ArticleTherapeutic advances in medical oncology2022

Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study.

Geoffroy Bilger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.